Serial Number | 88439354 |
Word Mark | ATAC |
Filing Date | Tuesday, May 21, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, November 1, 2022 |
Registration Number | 6886783 |
Registration Date | Tuesday, November 1, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 16, 2022 |
Goods and Services | Pharmaceutical preparations, namely, anti-cancer and immunosuppression preparations; pharmaceuticals, namely, anti-cancer and immunosuppression preparations; chemico-pharmaceutical preparations, namely, chemical preparations for medical purposes for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances, namely, pharmaceutical products for the treatment of cancer and immunosuppression; pharmaceutical preparations, namely, anti-cancer preparations for veterinary use; chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer and immunosupression; pharmaceutical preparations for human use, namely, pharmaceutical preparations for human use in the treatment of cancer and immnunosupression; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; diagnostic preparations for veterinary purposes; clinical diagnostic reagents for medical use; diagnostic chemical reagents for medical use; anti-cancer drugs, namely, anti-cancer preparations; pharmaceutical compounds for treating cancer and immunosuppression; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals, namely, anti-cancer preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; antibodies being pharmaceutical preparations for the treatment of cancer and immunosuppression; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression with agents including amatoxin |
Goods and Services | Pharmaceutical advice; pharmaceutical consultation services; consultancy and information services relating to pharmaceutical products; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression |
Goods and Services | Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; provision of medical research services; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; pharmaceutical research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific laboratory services relating to the production of monoclonal antibodies; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2019 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Heidelberg Pharma Research GmbH |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Ladenburg 68526 DE |
Party Name | Heidelberg Pharma Research GmbH |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Ladenburg 68526 DE |
Party Name | Heidelberg Pharma Research GmbH |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Ladenburg 68526 DE |
Event Date | Event Description |
Tuesday, November 1, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, November 1, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, August 16, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 16, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, July 27, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, July 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, July 6, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, July 5, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, July 5, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Thursday, January 13, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Thursday, January 13, 2022 | FINAL REFUSAL E-MAILED |
Thursday, January 13, 2022 | FINAL REFUSAL WRITTEN |
Monday, November 29, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 29, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, November 15, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Tuesday, October 5, 2021 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Tuesday, October 5, 2021 | INQUIRY TO SUSPENSION E-MAILED |
Tuesday, October 5, 2021 | SUSPENSION INQUIRY WRITTEN |
Wednesday, August 25, 2021 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
Tuesday, January 5, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, January 5, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, January 5, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, January 5, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, January 5, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Monday, December 7, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Monday, December 7, 2020 | LETTER OF SUSPENSION E-MAILED |
Monday, December 7, 2020 | SUSPENSION LETTER WRITTEN |
Friday, December 4, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, December 4, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 25, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Monday, November 23, 2020 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Monday, November 23, 2020 | INQUIRY TO SUSPENSION E-MAILED |
Monday, November 23, 2020 | SUSPENSION INQUIRY WRITTEN |
Monday, November 2, 2020 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
Monday, November 2, 2020 | ASSIGNED TO LIE |
Wednesday, February 26, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Wednesday, February 26, 2020 | LETTER OF SUSPENSION E-MAILED |
Wednesday, February 26, 2020 | SUSPENSION LETTER WRITTEN |
Tuesday, February 11, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, February 10, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, February 10, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, August 9, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, August 9, 2019 | NON-FINAL ACTION E-MAILED |
Friday, August 9, 2019 | NON-FINAL ACTION WRITTEN |
Thursday, August 8, 2019 | ASSIGNED TO EXAMINER |
Wednesday, June 5, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, May 24, 2019 | NEW APPLICATION ENTERED IN TRAM |